Daewoong Co., Ltd. (003090.KS)
KRW 20400.0
(-4.9%)
KRW 20400.0
(-4.9%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 728.62 Billion KRW | 5.24% |
| 2022 | 692.31 Billion KRW | 19.25% |
| 2021 | 580.54 Billion KRW | 9.87% |
| 2020 | 528.4 Billion KRW | 0.49% |
| 2019 | 525.84 Billion KRW | 13.84% |
| 2018 | 461.91 Billion KRW | 7.35% |
| 2017 | 430.28 Billion KRW | 7.69% |
| 2016 | 399.57 Billion KRW | 28.95% |
| 2015 | 309.86 Billion KRW | 10.86% |
| 2014 | 279.5 Billion KRW | -3.17% |
| 2013 | 288.64 Billion KRW | 268.57% |
| 2012 | 78.31 Billion KRW | 26.06% |
| 2011 | 62.12 Billion KRW | -69.51% |
| 2010 | 203.75 Billion KRW | -15.59% |
| 2009 | 241.38 Billion KRW | 9.88% |
| 2008 | 219.67 Billion KRW | 5.88% |
| 2007 | 207.47 Billion KRW | 22.74% |
| 2006 | 169.04 Billion KRW | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 186.18 Billion KRW | 2.7% |
| 2024 Q1 | 183.74 Billion KRW | -5.47% |
| 2023 Q2 | -401.22 Billion KRW | -325.41% |
| 2023 Q4 | 194.38 Billion KRW | 149.09% |
| 2023 FY | 728.62 Billion KRW | 5.24% |
| 2023 Q3 | -395.95 Billion KRW | 1.31% |
| 2023 Q1 | 177.99 Billion KRW | -8.07% |
| 2022 Q2 | 167.81 Billion KRW | 6.29% |
| 2022 FY | 692.31 Billion KRW | 19.25% |
| 2022 Q4 | 193.62 Billion KRW | 11.93% |
| 2022 Q3 | 172.98 Billion KRW | 3.08% |
| 2022 Q1 | 157.88 Billion KRW | -3.75% |
| 2021 Q3 | 137.42 Billion KRW | -6.32% |
| 2021 FY | 580.54 Billion KRW | 9.87% |
| 2021 Q1 | 132.38 Billion KRW | -2.54% |
| 2021 Q2 | 146.69 Billion KRW | 10.8% |
| 2021 Q4 | 164.03 Billion KRW | 19.37% |
| 2020 FY | 528.4 Billion KRW | 0.49% |
| 2020 Q4 | 135.83 Billion KRW | 4.96% |
| 2020 Q1 | 131.5 Billion KRW | -42.96% |
| 2020 Q2 | 131.64 Billion KRW | 0.11% |
| 2020 Q3 | 129.41 Billion KRW | -1.7% |
| 2019 FY | 525.84 Billion KRW | 13.84% |
| 2019 Q4 | 230.55 Billion KRW | 115.86% |
| 2019 Q1 | 121.02 Billion KRW | -4.24% |
| 2019 Q3 | 106.8 Billion KRW | -17.97% |
| 2019 Q2 | 130.21 Billion KRW | 7.59% |
| 2018 FY | 461.91 Billion KRW | 7.35% |
| 2018 Q1 | 110.25 Billion KRW | 131.75% |
| 2018 Q2 | 112.89 Billion KRW | 2.4% |
| 2018 Q4 | 126.38 Billion KRW | 12.46% |
| 2018 Q3 | 112.38 Billion KRW | -0.46% |
| 2017 Q4 | -347.2 Billion KRW | -229.62% |
| 2017 Q2 | 107.05 Billion KRW | 6.26% |
| 2017 FY | 430.28 Billion KRW | 7.69% |
| 2017 Q3 | 267.85 Billion KRW | 150.2% |
| 2017 Q1 | 100.74 Billion KRW | 2.48% |
| 2016 FY | 399.57 Billion KRW | 28.95% |
| 2016 Q2 | 100.4 Billion KRW | 8.82% |
| 2016 Q4 | 98.3 Billion KRW | -3.2% |
| 2016 Q1 | 92.26 Billion KRW | -1.79% |
| 2016 Q3 | 101.55 Billion KRW | 1.15% |
| 2015 Q4 | 93.94 Billion KRW | 18.45% |
| 2015 Q2 | 215.6 Billion KRW | 206.37% |
| 2015 FY | 309.86 Billion KRW | 10.86% |
| 2015 Q1 | 70.37 Billion KRW | -12.93% |
| 2015 Q3 | 79.31 Billion KRW | -63.21% |
| 2014 Q4 | 80.82 Billion KRW | 16.14% |
| 2014 FY | 279.5 Billion KRW | -3.17% |
| 2014 Q3 | 69.59 Billion KRW | 14.15% |
| 2014 Q2 | 60.96 Billion KRW | -10.49% |
| 2014 Q1 | 68.11 Billion KRW | -27.69% |
| 2013 FY | 288.64 Billion KRW | 268.57% |
| 2013 Q2 | 56 Million KRW | -99.92% |
| 2013 Q3 | 183.7 Billion KRW | 327933.98% |
| 2013 Q4 | 94.2 Billion KRW | -48.72% |
| 2013 Q1 | 71.15 Billion KRW | 165.72% |
| 2012 Q1 | -2.53 Billion KRW | 0.0% |
| 2012 FY | 78.31 Billion KRW | 26.06% |
| 2012 Q4 | -108.26 Billion KRW | -158.61% |
| 2012 Q3 | 184.73 Billion KRW | 5615.32% |
| 2012 Q2 | 3.23 Billion KRW | 227.73% |
| 2011 Q1 | 5.98 Billion KRW | 0.0% |
| 2011 FY | 62.12 Billion KRW | -69.51% |
| 2011 Q4 | - KRW | -100.0% |
| 2011 Q3 | 6.74 Billion KRW | -4.45% |
| 2011 Q2 | 7.05 Billion KRW | 18.02% |
| 2010 Q1 | - KRW | -100.0% |
| 2010 FY | 203.75 Billion KRW | -15.59% |
| 2010 Q2 | 7 Billion KRW | 0.0% |
| 2010 Q3 | 6.24 Billion KRW | -10.88% |
| 2009 Q3 | 6.2 Billion KRW | -7.87% |
| 2009 FY | 241.38 Billion KRW | 9.88% |
| 2009 Q1 | - KRW | -100.0% |
| 2009 Q2 | 6.73 Billion KRW | 0.0% |
| 2009 Q4 | 5.79 Billion KRW | -6.54% |
| 2008 Q4 | 7.13 Billion KRW | -0.63% |
| 2008 Q1 | - KRW | -100.0% |
| 2008 Q3 | 7.18 Billion KRW | -7.9% |
| 2008 Q2 | 7.79 Billion KRW | 0.0% |
| 2008 FY | 219.67 Billion KRW | 5.88% |
| 2007 Q2 | 7.22 Billion KRW | 0.0% |
| 2007 Q4 | 6.96 Billion KRW | 4.24% |
| 2007 FY | 207.47 Billion KRW | 22.74% |
| 2007 Q3 | 6.68 Billion KRW | -7.4% |
| 2006 FY | 169.04 Billion KRW | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| PharmGen Science, Inc. | 87.07 Billion KRW | -736.809% |
| Wooridul Huebrain Limited | 13.92 Billion KRW | -5132.973% |